Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J. McCarthy, Bruno Delafont, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes
Ryan E. Ross, Catherine J. VanDerwerker, Michael E. Saladin, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 298-328
Open Access | Times Cited: 100
Stress induced microglial activation contributes to depression
Bingjin Li, Wei Yang, Tongtong Ge, et al.
Pharmacological Research (2022) Vol. 179, pp. 106145-106145
Closed Access | Times Cited: 84
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 25
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Nicole Leite Galvão‐Coelho, Ana Cecília de Menezes Galvão, Raíssa Nóbrega de Almeida, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 10, pp. 1125-1133
Closed Access | Times Cited: 103
The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies
Vlad Dionisie, Gabriela Adriana Filip, Mihnea Costin Manea, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 75-90
Closed Access | Times Cited: 90
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 86
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
Anna Mosiołek, Aleksandra Pięta, Sławomir Jakima, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1706-1706
Open Access | Times Cited: 59
Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines
Xiying Fu, Yicun Wang, Fangyi Zhao, et al.
Aging (2023)
Open Access | Times Cited: 35
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 30
Advances in biosensors for major depressive disorder diagnostic biomarkers
Tao Dong, Chenghui Yu, Qi Mao, et al.
Biosensors and Bioelectronics (2024) Vol. 258, pp. 116291-116291
Closed Access | Times Cited: 9
Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan
Xiaojie Liu, Fuxiao Wei, Huanle Liu, et al.
Journal of Ethnopharmacology (2020) Vol. 268, pp. 113549-113549
Closed Access | Times Cited: 62
Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
Yanni Zhan, Yanling Zhou, Wei Zheng, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 60
Neuroimmunology of depression
Erika Sarno, Adam J. Moeser, Alfred J. Robison
Advances in pharmacology (2021), pp. 259-292
Open Access | Times Cited: 54
Inflammation as the Potential Basis in Depression
Sung Ho Maeng, Heeok Hong
International Neurourology Journal (2019) Vol. 23, Iss. Suppl 2, pp. S63-71
Open Access | Times Cited: 44
Aerobic Exercise Inhibits CUMS-Depressed Mice Hippocampal Inflammatory Response via Activating Hippocampal miR-223/TLR4/MyD88-NF-κB Pathway
Honglin Qu, Ruilian Liu, Jiaqin Chen, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 8, pp. 2676-2676
Open Access | Times Cited: 42
Flare‑up of cytokines in rheumatoid arthritis and their role in triggering depression: Shared common function and their possible applications in treatment (Review)
Zhang Chun-hai
Biomedical Reports (2020) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Inflammatory Biomarker and Response to Antidepressant in Major Depressive Disorder: a Systematic Review and Meta-Analysis.
Alessandra Gasparini, Camilla Callegari, Giulia Lucca, et al.
PubMed (2022) Vol. 52, Iss. 1, pp. 36-52
Closed Access | Times Cited: 23
White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
Sigrid Breit, Elena Mazza, Sara Poletti, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 22-32
Open Access | Times Cited: 14
The role of CCR5 in the protective effect of Esculin on lipopolysaccharide-induced depressive symptom in mice
Tong Chen, Menglin Zheng, Yixuan Li, et al.
Journal of Affective Disorders (2020) Vol. 277, pp. 755-764
Closed Access | Times Cited: 36
Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients
Anja Dvojkovic, Matea Nikolac Perković, Marina Šagud, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110016-110016
Closed Access | Times Cited: 35
Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
Breno S. Diniz, Benoit H. Mulsant, Charles F. Reynolds, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2219678-e2219678
Open Access | Times Cited: 20
Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
Shaojia Lu, Congchong Wu, Lili Jia, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Matea Nikolac Perković, Martin Gredičak, Marina Šagud, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 283-296
Closed Access | Times Cited: 11
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment
Karl Goodkin, Teresa H. Evering, Albert M. Anderson, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 11
Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders
Simon Wing-Fai Mok, Vincent Kam Wai Wong, Hang Hong Lo, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107480-107480
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top